This is not a problem that any one country, even wealthy G7 countries, can address on their own. It requires international work, because none of us is capable of doing it by ourselves.
If we're going to do a pull incentive, it makes no sense for the United Kingdom to do it by themselves, even though they've done an excellent job. It won't have impact unless the rest of Europe, the rest of the G7 and, eventually, the U.S. join.
If I could mention international co-operation with Dr. Wright, I've been to McMaster several times. I've been their guest for a day in which there was a lecture series. I know the world-class scientists they have there. Their sources of funding, in addition to Canada, are the U.S. NIH and European sources. I hope Dr. Wright's new molecule from Nature applies to CARB-X in the near future.
These things, in order to work.... He's identified this lack of an SBIR in Canada. Most U.S. applicants and many European applicants have received a couple of hundred thousand dollars after they've spun out in order to get their data lined up for an application to something like us. We're a charity. We don't take equity, but we require certain amounts of data. It's hard to do that without this extra translational device called an SBIR in the United States. It goes by different names—